OBJECTIVE: Interest in herbal treatments has increased without data on safety, efficacy, or rates of use in pregnancy. We examined antenatal herbal and natural product use among mothers of nonmalformed infants in 5 geographic centers. STUDY DESIGN: We used data on nonmalformed infants from the Slone Epidemiology Center's case-control surveillance program for birth defects to examine rates and predictors of herbal use. Exposures were identified through maternal interview. In addition to overall use, 5 categories based on traditional uses and 2 natural product categories were created; topical products and herbal-containing multivitamins were excluded. RESULTS: Among 4866 mothers of nonmalformed infants, 282 (5.8%) reported use of herbal or natural treatments. Use varied by study center and increased with increasing age. CONCLUSION: Although rates of use are low, there remains a need for investigation of the safety of these products. Given sparse data on efficacy, even small risks might well outweigh benefits. Copyright (c) 2010 Mosby, Inc. All rights reserved.
OBJECTIVE: Interest in herbal treatments has increased without data on safety, efficacy, or rates of use in pregnancy. We examined antenatal herbal and natural product use among mothers of nonmalformed infants in 5 geographic centers. STUDY DESIGN: We used data on nonmalformed infants from the Slone Epidemiology Center's case-control surveillance program for birth defects to examine rates and predictors of herbal use. Exposures were identified through maternal interview. In addition to overall use, 5 categories based on traditional uses and 2 natural product categories were created; topical products and herbal-containing multivitamins were excluded. RESULTS: Among 4866 mothers of nonmalformed infants, 282 (5.8%) reported use of herbal or natural treatments. Use varied by study center and increased with increasing age. CONCLUSION: Although rates of use are low, there remains a need for investigation of the safety of these products. Given sparse data on efficacy, even small risks might well outweigh benefits. Copyright (c) 2010 Mosby, Inc. All rights reserved.
Authors: Jerrie S Refuerzo; Sean C Blackwell; Robert J Sokol; Lorraine Lajeunesse; Katherine Firchau; Michael Kruger; Yoram Sorokin Journal: Am J Perinatol Date: 2005-08 Impact factor: 1.862
Authors: David L Hepner; Miriam Harnett; Scott Segal; William Camann; Angela M Bader; Lawrence C Tsen Journal: Anesth Analg Date: 2002-03 Impact factor: 5.108
Authors: Amit Sood; Richa Sood; Francis J Brinker; Ravneet Mann; Laura L Loehrer; Dietlind L Wahner-Roedler Journal: Am J Med Date: 2008-03 Impact factor: 4.965
Authors: Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz Journal: Am J Obstet Gynecol Date: 2011-04-22 Impact factor: 8.661
Authors: Abdul Rouf Pallivalappila; Derek Stewart; Ashalatha Shetty; Binita Pande; James S McLay Journal: Evid Based Complement Alternat Med Date: 2013-09-30 Impact factor: 2.629